Skip to Main Content

Paper Details

The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia.
Blood
4
2023
Author NameAffiliation
Charles G MullighanSt. Jude Children's Research Hospital
Charles G MullighanSt. Jude Children's Research Hospital
  • 1 - 2

Datasets

Release 1.2